ANCA Vasculitis Treatment in the Dialysis Patient

2021 ◽  
Vol 16 (11) ◽  
pp. 1617-1619
Author(s):  
Elizabeth Hendren ◽  
Jai Radhakrishnan
2006 ◽  
Vol 33 (S 1) ◽  
Author(s):  
A. Klein ◽  
S. Moskau ◽  
T. Klockgether ◽  
M. Linnebank

2019 ◽  
Vol 10 (02) ◽  
pp. 324-326 ◽  
Author(s):  
Ching Soong Khoo ◽  
Tze Yuan Tee ◽  
Hui Jan Tan ◽  
Raymond Azman Ali

ABSTRACTWe report a patient with end-stage renal disease on peritoneal dialysis, who developed encephalopathy after receiving a few doses of cefepime. He recovered clinically and electroencephalographically after having discontinued the culprit agent and undergone hemodialysis. This case highlights the importance of promptly recognizing this reversible encephalopathy, which can lead to the avoidance of unnecessary workup, reduce the length of hospital stay, and thereby improve the patients’ outcome.


2017 ◽  
Vol 18 (1) ◽  
Author(s):  
Valentine Gillion ◽  
Michel Jadoul ◽  
Selda Aydin ◽  
Nathalie Godefroid

2009 ◽  
Vol 9 (1) ◽  
Author(s):  
Yusuke Tsugawa ◽  
Miyuki Futatsuyama ◽  
Keiichi Furukawa ◽  
Fumika Taki ◽  
Yuji Nishizaki ◽  
...  

2002 ◽  
Vol 17 (4) ◽  
pp. 675-676 ◽  
Author(s):  
Barbara Thompson ◽  
Aine Burns ◽  
Andrew Davenport

Sign in / Sign up

Export Citation Format

Share Document